Coronavirus

A Central Science report from the CAS division of the American Chemical Society details developments and recommends directions against COVID-19 pandemic.

Countries around the world have struggled to keep the spread of COVID-19 in check. In countries with relatively few resources and weak public health infrastructure, the challenge is even more acute.

What does it look like when a health system switches from 'containment' to 'mitigation'?

Older people in low-income countries are especially at risk for COVID-19.

The European Union is rethinking its approach to border crossings as the region deals with the COVID-19 pandemic.

FDA grants emergency use authorization for Cepheid's point-of-care COVID-19 diagnostic, Xpert Xpress SARS-CoV-2.

Saskia v. Popescu, PhD, MPH, MA, CIC, a senior infection prevention epidemiologist in Phoenix, Arizona, discusses what it’s like for these frontline fighters and what we can do to “flatten the curve.”

Lopinavir-ritonavir worked against SARS, but it had little effect against coronavirus compared to standard care.

Stay on top of coronavirus developments from March 20, 2020.

New analyses of the novel coronavirus and previously circulating SARS viruses reveal promising immunologic targets for vaccine against COVID-19.

Several states are escalating their COVID-19 response measures.

Events that host at-risk people should consider canceling, postponing, or limiting in-person attendance.

The FDA has issued Emergency Use Authorization for another COVID-19 test, produced by Genmark Diagnostics.

A new paper describes how one Singaporean hospital responded to the 2003 severe acute respiratory syndrome (SARS) outbreak, and how those lessons can inform the response to the current pandemic.

The agency notes that they are working closely with industry officials to expedite efforts to develop countermeasures for COVID-19.

Stay on top of coronavirus developments from March 19, 2020.

Contagion® is partnering with PER® to provide CME to support clinicians during the global coronavirus pandemic.

A drug known to inhibit a cellular protease TMPRSS2 could potentially be a novel therapeutic intervention for COVID-19 infections, according to German investigators who found that the cellular protein may allow entry of SARS-CoV-2 into lung cells.

The NIH has shared new information on the stability of SARS-CoV-2 virus on a variety of surfaces.

According to Abbott, the systems can run high volumes of up to 470 tests in 24 hours.

Stay on top of coronavirus developments from March 18, 2020.

An American physics teacher living in Nanjing, China shares his experience with the coronavirus outbreak response.

The FDA has issued new guidance for conducting clinical trials during the COVID-19 pandemic.

Study authors provided a detailed summary of the Lombardy region of Italy’s response to the coronavirus outbreak crisis.

The president is urging people to limit social interactions for the next 15 days, including groups of 10 or more.

Stay on top of coronavirus developments from March 17, 2020.

Coronaviruses appear to affect children less commonly and when they do, result in much more mild symptoms and are less likely to lead to severe disease.

The study followed up with 347 contacts of a coronavirus patient to see if they developed symptoms.

Many of the features of telemedicine are well-suited for helping patients with COVID-19 while minimizing the risk to health care workers.

The trial will enroll 45 health adult participants between the ages of 18 to 55 years of age over a 6-week period. The first trial participant received the investigation vaccine, mRNA-1273, today.